Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
Annals of Surgical Oncology|February 29, 2020
MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive LymphocytesChristoph Fraune, Eike Burandt, Ronald Simon, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 2, 2023
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian CancerSören Weidemann, Natalia Gorbokon, Maximilian Lennartz, et al.
Pathology, Research and Practice|November 9, 2024
PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entitiesSekander Scherzai, Maximilian Lennartz, Frank Jacobsen, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
The Journal of Pathology. Clinical Research|August 7, 2021
Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumorsViktor Reiswich, Natalia Gorbokon, Andreas M Luebke, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Pageof 17